Dalton Greiner Hartman Maher & Co. lowered its position in NCI, Inc. (NASDAQ:NCIT) by 27.0% during the second quarter, Holdings Channel reports. The fund owned 89,731 shares of the information technology services provider’s stock after selling 33,172 shares during the period. Dalton Greiner Hartman Maher & Co.’s holdings in NCI were worth $1,893,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in NCIT. Royce & Associates LP bought a new stake in shares of NCI during the first quarter worth $7,663,000. Goldman Sachs Group Inc. bought a new stake in shares of NCI during the first quarter worth $432,000. Renaissance Technologies LLC boosted its stake in shares of NCI by 5.2% in the first quarter. Renaissance Technologies LLC now owns 404,799 shares of the information technology services provider’s stock worth $6,092,000 after buying an additional 20,074 shares during the last quarter. Russell Investments Group Ltd. bought a new stake in shares of NCI during the fourth quarter worth $216,000. Finally, Hancock Holding Co. bought a new stake in shares of NCI during the first quarter worth $189,000. Institutional investors and hedge funds own 39.04% of the company’s stock.
NCI, Inc. (NCIT) remained flat at $19.95 during mid-day trading on Friday. 186,907 shares of the company were exchanged. The firm has a market capitalization of $270.34 million, a PE ratio of 44.63 and a beta of 1.05. NCI, Inc. has a 12-month low of $10.98 and a 12-month high of $21.40. The stock’s 50-day moving average price is $20.18 and its 200 day moving average price is $16.03.
NCI (NASDAQ:NCIT) last announced its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 EPS for the quarter, topping the consensus estimate of $0.21 by $0.04. The business had revenue of $78.75 million for the quarter, compared to the consensus estimate of $76.55 million. NCI had a return on equity of 11.73% and a net margin of 2.13%. Equities analysts anticipate that NCI, Inc. will post $1.00 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Dalton Greiner Hartman Maher & Co. Reduces Stake in NCI, Inc. (NCIT)” was originally reported by BNB Daily and is owned by of BNB Daily. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.baseball-news-blog.com/2017/07/22/dalton-greiner-hartman-maher-co-reduces-stake-in-nci-inc-ncit.html.
NCIT has been the topic of a number of research reports. SunTrust Banks, Inc. reiterated a “buy” rating on shares of NCI in a research report on Monday, June 26th. Noble Financial reiterated a “buy” rating on shares of NCI in a research report on Friday, May 12th. ValuEngine upgraded NCI from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Cowen and Company reiterated a “buy” rating and set a $24.00 price target on shares of NCI in a research report on Monday, July 3rd. Finally, Zacks Investment Research cut NCI from a “hold” rating to a “sell” rating in a research report on Saturday, April 8th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $18.33.
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
Want to see what other hedge funds are holding NCIT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NCI, Inc. (NASDAQ:NCIT).
Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.